Disclosure Of Intangible Assets [Text Block]

Ascelia Pharma - Filing #678716

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
Disclosure of intangible assets [text block]
Note
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
57 074 SEK
57 074 SEK
Research and development expense
81 266 SEK
118 113 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.